Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kalbe Farma Tbk (KLBF) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kalbe Farma TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kalbe Farma Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp735 (market cap 35.34T, 108.3M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 212.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (108.3M versus 324K). Which is the better fit depends on your goals.

KLBFOBAT
Market Cap
35.34T166.01B
Volume
108.3M324K
Lot
1.08M3.24K
Turnover
80.02B77.68M
Average Price
738.89239.75
Value
80.02B77.68M
Indicative Equilibrium Price
735240
Indicative Equilibrium Volume
59.74K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KLBF
View details
OBAT
View details

About Kalbe Farma Tbk

PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.

Read more on KLBF

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT